Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.36 |
| ▸ | LPL | P06858 | 1/20 | 0.35 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.35 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | AR | P10275 | 2/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | GFER | P55789 | 1/20 | 0.35 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.35 |
| ▸ | RELA | Q04206 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL81005 | 0.93 | PDK2 (0.37) | PDK2 | |
| SCHEMBL80234 | 0.93 | PDK2 (0.37) | PDK2 | |
| SCHEMBL81212 | 0.92 | MAOB (0.41) | MAOBCYP1A2LPLLIPGKCNH2 | |
| SCHEMBL81080 | 0.92 | PDK2 (0.36) | PDK2 | |
| SCHEMBL80998 | 0.92 | PDK2 (0.36) | PDK2 | |
| SCHEMBL81955 | 0.92 | MAOB (0.38) | MAOBCYP1A2KCNH2ALDH1A1AR | |
| SCHEMBL80773 | 0.91 | PDK2 (0.38) | PDK2 | |
| SCHEMBL81931 | 0.91 | PDK2 (0.35) | PDK2 | |
| SCHEMBL80251 | 0.91 | MAOB (0.38) | MAOBCYP1A2LPLLIPGKCNH2 | |
| SCHEMBL81461 | 0.90 | PDK2 (0.39) | PDK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8841004-B2 | Binaphthyl compound and organic light emitting element using the same | CANON KABUSHIKI KAISHA (JP) | 2014-09-23 | — | — | US | disclosed |
| US-8841004-B2 | Binaphthyl compound and organic light emitting element using the same | CANON KABUSHIKI KAISHA (JP) | 2014-09-23 | — | — | US | disclosed |
| US-20120061657-A1 | BINAPHTHYL COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT USING THE SAME | CANON KABUSHIKI KAISHA (JP) | 2012-03-15 | — | — | US | disclosed |
| US-20120061657-A1 | BINAPHTHYL COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT USING THE SAME | CANON KABUSHIKI KAISHA (JP) | 2012-03-15 | — | — | US | disclosed |
| US-8084937-B2 | Binaphthyl compound and organic light emitting element using the same | CANON KABUSHIKI KAISHA (JP) | 2011-12-27 | — | — | US | disclosed |
| US-8084937-B2 | Binaphthyl compound and organic light emitting element using the same | CANON KABUSHIKI KAISHA (JP) | 2011-12-27 | — | — | US | disclosed |
| US-20090091252-A1 | BINAPHTHYL COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT USING THE SAME | CANON KABUSHIKI KAISHA (JP) | 2009-04-09 | — | — | US | disclosed |
| US-20090091252-A1 | BINAPHTHYL COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT USING THE SAME | CANON KABUSHIKI KAISHA (JP) | 2009-04-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090091252-A1 | BINAPHTHYL COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT USING THE SAME | ALPL, MT-ND4L, LAGE3 | MAOB 2835/4885CYP1A2 310/4885LPL 1254/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.